Activation of LA-N-2 cell phospholipases by single alanine substitution analogs of amyloid beta peptide (25-35)

被引:11
|
作者
Singh, IN
Sato, K
Takashima, A
Kanfer, JN
机构
[1] UNIV MANITOBA,DEPT BIOCHEM & MOL BIOL,WINNIPEG,MB R3E 0W3,CANADA
[2] MITSUBISHI KASEI INST LIFE SCI,MACHIDA,TOKYO 194,JAPAN
关键词
Alzheimer's disease; amyloid beta peptide; phospholipase A2; phospholipase C; phospholipase D; analogue;
D O I
10.1016/S0014-5793(97)00154-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A series of single alanine substituted analogs of amyloid beta peptide (25-35) were tested for their ability to activate the phospholipases of cultured LA-N-2 cells. Substitution of alanine for the amino acids 29-34 prevented the activation of phospholipases A2 and D. In addition substitution of alanine at 28 prevented phospholipase D but not phospholipase A2 activation. All the alanine substitutions, except for positions 33 and 35, blunted phospholipase C activations. There were no activations by scrambled amyloid beta peptide. (C) 1997 Federation of European Biochemical Societies.
引用
收藏
页码:65 / 67
页数:3
相关论文
共 50 条
  • [21] Amyloid Beta-Peptide 25-35 (Aβ25-35) Induces Cytotoxicity via Multiple Mechanisms: Roles of the Inhibition of Glucosylceramide Synthase by Aβ25-35 and Its Protection by D609
    Tang, Zhihui
    Motoyoshi, Kaisei
    Honda, Takuya
    Nakamura, Hiroyuki
    Murayama, Toshihiko
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2021, 44 (10) : 1419 - 1426
  • [22] Inhibition of toxicity in the β-amyloid peptide β(25-35) using N-methylated derivatives
    Doig, A
    Hughes, E
    Burke, R
    Lu, J
    Su, TJ
    Heenan, R
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S107 - S108
  • [23] Amyloid β-peptide(25-35) changes [Ca2+] in hippocampal neurons
    Mogensen, HS
    Beatty, DM
    Morris, SJ
    Jorgensen, OS
    NEUROREPORT, 1998, 9 (07) : 1553 - 1558
  • [24] MAPKs mediate the activation of cytosolic phospholipase A2 by amyloid β(25-35) peptide in bovine retina pericytes
    Nicotra, A
    Lupo, G
    Giurdanella, G
    Anfuso, CD
    Ragusa, N
    Tirolo, C
    Marchetti, B
    Alberghina, M
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2005, 1733 (2-3): : 172 - 186
  • [25] AMYLOID BETA-PROTEIN FRAGMENT 25-35 CAUSES ACTIVATION OF CYTOPLASMIC CALCIUM IN NEURONS
    JOSEPH, R
    HAN, E
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 184 (03) : 1441 - 1447
  • [26] GABA transporter 2 expression in hippocampus after β-amyloid peptide (Aβ25-35) injection
    Takagi, Shoko
    Nishioka, Kasumi
    Ueda, Ryo
    Ibi, Daisuke
    Mamiya, Takayoshi
    Kojima, Ryoji
    Hiramatsu, Masayuki
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2016, 130 (03) : S231 - S231
  • [27] SUCCESSFUL SYNTHESES OF BETA-AMYLOID-(25-35)-PEPTIDE - A DIFFICULT SEQUENCE BY N-(9-FLUORENYLMETHOXYCARBONYL) CHEMISTRY
    GUTHRIE, DJS
    ELAGNAF, O
    HARRIOTT, P
    IRVINE, GB
    WALKER, B
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1994, 22 (04) : 1052 - 1054
  • [28] In vitro aggregation facilitates beta-amyloid peptide-(25-35)-induced amnesia in the rat
    Delobette, S
    Privat, A
    Maurice, T
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 319 (01) : 1 - 4
  • [29] Effect of the beta-sheet-breaker peptide LPFFD on oriented network of amyloid β25-35 fibrils
    Murvai, Unige
    Soos, Katalin
    Penke, Botond
    Kellermayer, Miklos S. Z.
    JOURNAL OF MOLECULAR RECOGNITION, 2011, 24 (03) : 453 - 460
  • [30] Three-dimensional structures of the amyloid beta peptide (25-35) in membrane-mimicking environment
    Kohno, T
    Kobayashi, K
    Maeda, T
    Sato, K
    Takashima, A
    BIOCHEMISTRY, 1996, 35 (50) : 16094 - 16104